Sunday, 28 June 2026European Markets

#cell therapy

2 articles

Novo Nordisk Exits Internal Cell Therapy, Licenses Parkinson's Program to AI Partner

European Biotech

Novo Nordisk Exits Internal Cell Therapy, Licenses Parkinson's Program to AI Partner

Salvado•Jun 25, 2026

Novo Nordisk Licenses Parkinson's Cell Therapy to AI Partner, Closes Internal Unit

European Pharma

Novo Nordisk Licenses Parkinson's Cell Therapy to AI Partner, Closes Internal Unit

Salvado•May 16, 2026